Efficacy and Safety Ranking of HER2-Targeted TKIs in Advanced Breast Cancer: A Bayesian Network Meta-Analysis. Li R, Huangfu R, Lan H, Zhang C, et al. Clin Med Insights Oncol 2026;20:11795549261489524.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li R, Huangfu R, Lan H, Zhang C, et al. Efficacy and Safety Ranking of HER2-Targeted TKIs in Advanced Breast Cancer: A Bayesian Network Meta-Analysis. Clin Med Insights Oncol 2026;20:11795549261489524.
PMID: 42756652